Literature DB >> 10874582

Dopamine D4 receptors.

D M Helmeste1, S W Tang.   

Abstract

Initial investigations on dopamine D4 receptors generated much interest in the role of this receptor in schizophrenia and other aspects of human behavior, as well as new opportunities for novel therapeutics. However, attempts to treat patients suffering from schizophrenia with dopamine D4 agents have failed to yield satisfactory results so far. An examination of the dopamine D4 literature shows that contrasting and conflicting data seemed to be the norm in this field of research. This paper reviews the literature on the dopamine D4 receptor and discusses many of the associated methodological problems that might have contributed to the paradoxical findings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874582     DOI: 10.1254/jjp.82.1

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  5 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase.

Authors:  Pieter Rondou; Guy Haegeman; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  J Biol Chem       Date:  2008-02-26       Impact factor: 5.157

3.  Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Authors:  P K Thanos; C Bermeo; M Rubinstein; K L Suchland; G J Wang; D K Grandy; N D Volkow
Journal:  J Psychopharmacol       Date:  2009-03-12       Impact factor: 4.153

4.  Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex.

Authors:  Tonya M Gerald; Allyn C Howlett; Gregg R Ward; Cheryl Ho; Steven O Franklin
Journal:  Psychopharmacology (Berl)       Date:  2008-04-27       Impact factor: 4.530

5.  KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 Variant.

Authors:  Kamila Skieterska; Pieter Rondou; Béatrice Lintermans; Kathleen Van Craenenbroeck
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.